Immunovant (IMVT)
Developing imeroprubart across six IgG-driven autoimmune diseases.
$37.29
After hours0.00 (0.00%)
At close$37.29(+0.30%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 48 days
EPS estimate
−$0.73
Revenue estimate
$7.1M
Fiscal quarter
Q2 FY27
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.76−$0.64−$0.60−$0.73−$0.61−$0.73−$0.75Pending
Estimate−$0.73−$0.71−$0.69−$0.72−$0.72−$0.59−$0.63−$0.73
Surprise−4.1%+10.3%+13.0%−1.4%+15.3%−23.3%−19.3%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported——————$7.1MPending
Estimate————$6.0M—$7.1M$7.1M
Surprise——————0.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Mar 2029 | −$0.48 | — | — |
| Dec 2028 | −$0.50 | — | — |
| Sep 2028 | −$0.58 | — | — |
| Jun 2028 | −$0.60 | — | — |
| Mar 2028 | −$0.78 | — | — |
| Dec 2027 | −$0.76 | — | — |
| Sep 2027 | −$0.73 | — | — |
| Jun 2027 | −$0.73 | — | — |
| Mar 2027 | −$0.73 | — | — |
| Dec 2026 | −$0.73 | — | — |
| Nov 2026 | −$0.73 | — | — |
| Aug 2026 | −$0.63 | −$0.75 | −19.3% |
| May 2026 | −$0.59 | −$0.73 | −23.3% |
| Feb 2026 | −$0.72 | −$0.61 | +15.3% |
| Nov 2025 | −$0.72 | −$0.73 | −1.4% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Mar 2029 | −$0.48 | — | — | $7.1M | — | — | — |
| Dec 2028 | −$0.50 | — | — | $7.1M | — | — | — |
| Sep 2028 | −$0.58 | — | — | $7.1M | — | — | — |
| Jun 2028 | −$0.60 | — | — | $7.1M | — | — | — |
| Mar 2028 | −$0.78 | — | — | $32.3M | — | — | — |
| Dec 2027 | −$0.76 | — | — | $7.1M | — | — | — |
| Sep 2027 | −$0.73 | — | — | $7.1M | — | — | — |
| Jun 2027 | −$0.73 | — | — | $7.1M | — | — | — |
| Mar 2027 | −$0.73 | — | — | $14.4M | — | — | — |
| Dec 2026 | −$0.73 | — | — | $7.1M | — | — | — |
| Nov 9, 2026 | −$0.73 | — | — | $7.1M | — | — | — |
| Aug 6, 2026 | −$0.63 | −$0.75 | −19.3% | $7.1M | $7.1M | 0.0% | +1.2% |
| May 20, 2026 | −$0.59 | −$0.73 | −23.3% | — | — | — | +35.3% |
| Feb 6, 2026 | −$0.72 | −$0.61 | +15.3% | $6.0M | — | — | +12.4% |
| Nov 10, 2025 | −$0.72 | −$0.73 | −1.4% | — | — | — | +0.1% |
| Aug 11, 2025 | |||||||
| May 29, 2025 | |||||||
| Feb 6, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 29, 2024 | |||||||
| Feb 12, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 22, 2023 | |||||||
| Feb 3, 2023 | |||||||
| Nov 4, 2022 | |||||||
| Aug 5, 2022 | |||||||
| Jun 8, 2022 | |||||||
| Feb 4, 2022 | |||||||
| Nov 5, 2021 | |||||||
| Aug 9, 2021 | |||||||
| Jun 1, 2021 | |||||||
| Feb 16, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 12, 2020 | |||||||
| Jun 29, 2020 | |||||||
| Feb 14, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 12, 2019 | |||||||
| Jun 12, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 |